BRIANNA HODEN: Open Payments
NPI 1245780659 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 28 payments from 8 companies in 2025. Trend: 2023 $518 · 2024 $211 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $156 |
| PFIZER INC. | 3 | $62 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| ABIOMED | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Amgen Inc. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| BridgeBio Pharma, Inc. | 1 | $25 |
Products named: LEQVIO, VERQUVO, REPATHA, VYNDAQEL, JARDIANCE, ONPATTRO, ELIQUIS, Attruby.
Industry payments across KS — which companies pay providers there.
